Detalhe da pesquisa
1.
Clinical Profiles of Japanese Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Collected by a Nationwide System from 2006 to 2023.
Biol Pharm Bull
; 47(1): 88-97, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38171782
2.
Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians.
Br J Clin Pharmacol
; 81(6): 1078-90, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26774055
3.
IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement.
J Allergy Clin Immunol
; 135(6): 1538-45.e17, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25672763
4.
Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method.
BMC Cancer
; 15: 718, 2015 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26475168
5.
Genetic factors associated with gemcitabine pharmacokinetics, disposition, and toxicity.
Pharmacogenet Genomics
; 24(1): 15-25, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24225399
6.
Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
JAMA
; 312(5): 525-34, 2014 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25096692
7.
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
J Hum Genet
; 58(6): 317-26, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23635947
8.
Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant.
Immunogenetics
; 64(12): 869-77, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22903236
9.
Survival prediction for pancreatic cancer patients receiving gemcitabine treatment.
Mol Cell Proteomics
; 9(4): 695-704, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20061307
10.
[Exploratory study on biomarkers associated with severe cutaneous adverse reactions].
Yakugaku Zasshi
; 131(2): 255-61, 2011 Feb.
Artigo
em Japonês
| MEDLINE | ID: mdl-21297371
11.
[Current movements of four serious adverse events induced by medicinal drugs based on spontaneous reports in Japan].
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku
; (129): 111-7, 2011.
Artigo
em Japonês
| MEDLINE | ID: mdl-22259851
12.
HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.
Epilepsia
; 51(2): 297-300, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19694795
13.
HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
Epilepsia
; 51(12): 2461-5, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21204807
14.
Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients.
Br J Clin Pharmacol
; 70(2): 222-33, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20653675
15.
Drugs causing severe ocular surface involvements in Japanese patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Allergol Int
; 64(4): 379-81, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26433536
16.
Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjects.
Drug Metab Dispos
; 37(9): 1895-903, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19541829
17.
Close association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 haplotype and its apparent influence on 7-ethyl-10-hydroxycamptothecin (SN-38) glucuronidation in Japanese.
Drug Metab Dispos
; 37(2): 272-6, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18981166
18.
[Exploratory studies on genetic biomarkers related to serious drug adverse reactions].
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku
; (127): 1-14, 2009.
Artigo
em Japonês
| MEDLINE | ID: mdl-20306701
19.
Importance of UDP-glucuronosyltransferase 1A1*6 for irinotecan toxicities in Japanese cancer patients.
Cancer Lett
; 261(2): 165-71, 2008 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-18082937
20.
Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients.
Cancer Chemother Pharmacol
; 62(3): 529-37, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17992531